MicroGenDX Blog

A Critical Issue Affecting Millions of Women Intrauterine devices represent one of the most effective forms of long-acting reversible contraception available today, with efficacy rates comparable to sterilization methods. Yet despite their clinical advantages, a staggering 57% of IUD patients in the United States choose to have their devices removed before the recommended duration of use. This represents not just a contraceptive failure, but a missed opportunity to provide sustained, reliable reproductive health management to millions of women. For clinicians managing IUD patients, these premature removals translate into valuable clinical time spent addressing complications, counseling disappointed patients, and navigating alternative […]

Periprosthetic joint infections (PJI) remain one of the most serious and costly complications associated with total joint arthroplasty. Although they occur in 1–2% of cases, the consequences are severe—ranging from multiple revision surgeries and prolonged hospital stays to reduced patient mobility and increased mortality risk.  Beyond clinical outcomes, the financial burden is substantial, with average cost of $100,000 per episode and lifetime costs reaching roughly $391,000 per patient. A particularly complex clinical challenge arises when PJIs are culture-negative, which occurs in an estimated 15–30% of cases. When standard microbiological cultures fail to identify a culprit pathogen, orthopedic surgeons and infectious […]

In neurologic infection cases, time determines patient outcomes. Delays in identifying the cause of infection can lead to extended ICU stays, major complications, or diminished quality of life for patients. Traditional culture methods can take days and sometimes weeks to yield results—time that neither physicians or their patients have. Our integration of the Illumina MiSeq i100 Plus enables delivery of Next-Gen DNA Sequencing (NGS) results as soon as 24 hours after sample receipt. This advancement is providing neurologists and infectious disease specialists with insights when they need them most, reducing diagnostic delays. By minimizing the time lag between testing and […]

In clinical diagnostics, the accuracy and reliability of test results are paramount. As a healthcare provider, the MicroGenDX team understands you expect the diagnostic tools you recommend to your patients to be both precise and trustworthy. The MicroGenDX team takes this responsibility seriously, and our commitment to accuracy is reflected in the rigorous validation and oversight processes of our accreditation and regulatory partners. This blog takes a closer look at the validation and quality monitoring processes required by the College of American Pathologists (CAP) and other regulatory bodies and how MicroGenDX meets these standards to achieve our high accuracy. The […]

MicroGenDX Adopts Illumina i100 Plus to Deliver Faster, More Reliable NGS Result At-a-Glance: What the i100 Plus Means for Your Practice NGS results in 24 hours after sample receipt, with an 80% faster turnaround, creating faster molecular diagnostics that keep pace with in-house PCR panel processing. 4x greater sequencing depth improves detection of low-abundance/low-frequency microbes for more complete microbial visibility. More data per sequencing read increases reliability of results and confidence in microbial detection. A single, combined report delivers both qPCR and NGS results at once. Quickens timeline for precision clinical decision-making across urology, ENT, OB/GYN, wound care, and other […]